Related references
Note: Only part of the references are listed.Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
Aryeh Fischer et al.
JOURNAL OF RHEUMATOLOGY (2013)
Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
Argyris Tzouvelekis et al.
PULMONARY MEDICINE (2012)
Effect of mycophenolate sodium in scleroderma-related interstitial lung disease
Carmen Pilar Simeon-Aznar et al.
CLINICAL RHEUMATOLOGY (2011)
Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
Mary Anne Dooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
Athanasios Koutroumpas et al.
CLINICAL RHEUMATOLOGY (2010)
HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities
M. Bellia et al.
RADIOLOGIA MEDICA (2009)
Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
Anthony J. Gerbino et al.
CHEST (2008)
High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease
Jonathan G. Goldin et al.
CHEST (2008)
Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
Ana C. Zamora et al.
RESPIRATORY MEDICINE (2008)
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
Carlotta Nannini et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Mycophenolate mofetil for interstitial lung disease in scleroderma
S. C. Plastiras et al.
RHEUMATOLOGY (2006)
Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease
S. N. C. Liossis et al.
RHEUMATOLOGY (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection
AC Allison et al.
TRANSPLANTATION (2005)
Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy
V Majithia et al.
RHEUMATOLOGY (2005)
Share Paper
